tpMSCs

Tenogent primed allogeneic mesenchymal stem cells (tpMSCs) derived from equine peripheral blood represent an advanced biological treatment for regenerative therapy. TpMSCs are used to promote tissue healing in animals, particularly in orthopedic and musculoskeletal conditions. Read more

Tenogent primed allogeneic mesenchymal stem cells (tpMSCs) derived from equine peripheral blood represent an advanced biological treatment for regenerative therapy. TpMSCs are used to promote tissue healing in animals, particularly in orthopedic and musculoskeletal conditions.

Essential insights

• Immunomodulation: TpMSCs modulate the immune response by reducing inflammation and promoting tissue repair through the secretion of cytokines and growth factors.
• Regenerative Capacity: These stem cells stimulate the formation of new tissue, particularly collagen and extracellular matrix, essential for repairing damaged tendons, ligaments, and joints.
• Allogeneic Use: TpMSCs are engineered to be immunologically compatible, minimizing rejection risk and enabling widespread application across species.